> ## Content Index
> Fetch the complete content index at: https://members.americanhealthintel.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# CMS finalizes the TAVR coverage rewrite, heart team survives
- URL: https://members.americanhealthintel.com/2026-09-22-serviceline/
- Published: 2026-09-23T00:09:56.000Z
- Updated: 2026-09-23T00:09:56.000Z
- Description: Plus: ACC asks CMS to delay mandatory heart-failure model, reverse procedure cuts. The day's rules, money, and enforcement, sourced and tiered below.
- Author: American Health Intel

Plus: ACC asks CMS to delay mandatory heart-failure model, reverse procedure cuts. The day's rules, money, and enforcement, sourced and tiered below.

| American Health Intel Rules · Money · Medicine · Decoded daily The Service Line Tuesday, September 22, 2026 CMS finalizes the TAVR coverage rewrite, heart team survives Plus: ACC asks CMS to delay mandatory heart-failure model, reverse procedure cuts. The day's rules, money, and enforcement, sourced and tiered below. ![](https://americanhealthintel.com/email/pulse-divider.png) Record CMS closed a nine-month fight this week: its rewritten Medicare coverage rule for TAVR, the catheter-based heart valve replacement, drops a registry requirement for the sickest patients but keeps cardiac surgeons on every case. The new National Coverage Determination drops the evidence-development registry for symptomatic patients, adds asymptomatic coverage under research only, and sets a 20-procedures-a-year operator floor instead of a hospital volume minimum. Record The American College of Cardiology, the specialty's largest physician group, wants CMS to delay its mandatory heart-failure payment model and reverse double-digit pay cuts to heart valve and imaging procedures. ACC's CY2027 fee schedule comments ask CMS to make the Ambulatory Specialty Model's first year no-risk and delay its Jan 1, 2027 start, plus restore RUC-recommended pay for left atrial appendage closure, tricuspid valve repair, and IVUS. Also today No new cardiology settlement; OIG's remote monitoring audit is the thread to watch [Read](https://americanhealthintel.com/editions/2026-09-22-serviceline/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition#rpm-cardiac-monitoring-oig-audit-2026) Small FL cardiology tie-up previews PE's second-bite recap wave [Read](https://americanhealthintel.com/editions/2026-09-22-serviceline/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition#clearwater-pasco-cardiology-secondbite) HRS: most wrongful EP prior-auth denials never get appealed [Read](https://americanhealthintel.com/editions/2026-09-22-serviceline/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition#hrs-prior-auth-ep-position-statement) The new TAVR operator volume floor every program must track [Read](https://americanhealthintel.com/editions/2026-09-22-serviceline/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition#tavr-operator-volume-floor-metric) 720Records$38.9BEnforcement32Deadlines186Rules [Read this issue + the trackers](https://americanhealthintel.com/editions/2026-09-22-serviceline/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) Pick your field on the site and every story tells you what it means for you. Reply to this email and tell us what you want covered. We read everything. We show our work. We score our own calls. [Track record](https://americanhealthintel.com/ledger/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) · [Calendar](https://americanhealthintel.com/calendar/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) · [Enforcement](https://americanhealthintel.com/enforcement/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) · [X](https://x.com/amhealthintel?ref=members.americanhealthintel.com) · [LinkedIn](https://www.linkedin.com/company/american-health-intel?ref=members.americanhealthintel.com) News and analysis, not legal, medical, coding, or investment advice.You subscribed at americanhealthintel.com · [Unsubscribe](%%{unsubscribe%5Furl}%%) |
| ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ |